Ki Summary

Reaction Details

Report a problem with these data

Target

GTPase KRas [G12C]

Ligand

BDBM608859

Substrate/Competitor

n/a

Meas. Tech.

Scintillation Proximity Assay (SPA)

IC50

11.0±n/a nM

Citation

Cotesta, S; Gerspacher, M; Leblanc, C; Lorthiois, EL; Liu, B; Machauer, R; Mah, R; Mura, C; Rigollier, P; Schneider, N; Stutz, S; Vaupel, A; Warin, N; Wilcken, R Pyrazolyl derivatives useful as anti-cancer agents US Patent US11702409 Publication Date 7/18/2023

More Info.:

Get all data from this article, Assay Method

GTPase KRas [G12C]

Name:

GTPase KRas [G12C]

Synonyms:

GTPase KRas (G12C) | KRAS | KRAS2 | RASK2 | RASK_HUMAN

Type:

Enzyme Catalytic Domain

Mol. Mass.:

21702.19

Organism:

Homo sapiens (Human)

Description:

P01116[G12C]

Residue:

189

Sequence:

MTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDL
PSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGC
VKIKKCIIM

BDBM608859

n/a

Name

BDBM608859

Synonyms:

US11702409, Example 16a | US11702409, Example 16b

Type

Small organic molecule

Emp. Form.

C32H35ClN8O

Mol. Mass.

583.126

SMILES

CN(C)CCn1cc2cc(ccc2n1)-c1nn(C2CC3(C2)CN(C3)C(=O)C=C)c(C)c1-c1c(Cl)c(C)cc2[nH]ncc12 |(5.96,.58,;7.44,.98,;7.84,2.47,;8.53,-.11,;8.13,-1.59,;6.65,-1.99,;5.5,-.96,;4.17,-1.73,;2.7,-1.26,;1.56,-2.29,;1.88,-3.79,;3.35,-4.27,;4.49,-3.24,;6.02,-3.4,;.1,-1.81,;-.38,-.35,;-1.92,-.35,;-2.69,.99,;-4.18,1.39,;-3.78,2.87,;-2.29,2.48,;-5.27,3.27,;-4.87,4.76,;-3.38,4.36,;-5.96,5.85,;-5.56,7.34,;-7.44,5.45,;-8.53,6.54,;-2.4,-1.81,;-3.86,-2.29,;-1.15,-2.72,;-1.15,-4.26,;-2.48,-5.03,;-3.82,-4.26,;-2.48,-6.57,;-3.82,-7.34,;-1.15,-7.34,;.18,-6.57,;1.65,-7.04,;2.55,-5.8,;1.65,-4.55,;.18,-5.03,)|

Structure